Free Trial

Oscar Health, Inc. (NYSE:OSCR) Shares Sold by Healthcare of Ontario Pension Plan Trust Fund

Oscar Health logo with Finance background

Healthcare of Ontario Pension Plan Trust Fund reduced its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 76.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,100 shares of the company's stock after selling 291,600 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund's holdings in Oscar Health were worth $1,953,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd purchased a new position in shares of Oscar Health in the 2nd quarter valued at approximately $78,000. Quest Partners LLC purchased a new stake in Oscar Health in the second quarter valued at $93,000. KBC Group NV grew its position in Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after purchasing an additional 1,328 shares during the period. Amalgamated Bank raised its stake in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company's stock valued at $106,000 after buying an additional 1,458 shares during the last quarter. Finally, Optimum Investment Advisors purchased a new stake in shares of Oscar Health in the third quarter worth about $142,000. Institutional investors own 75.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Bank of America cut Oscar Health from a "neutral" rating to an "underperform" rating and reduced their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Piper Sandler restated an "overweight" rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a "neutral" rating and a $23.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $22.93.

Read Our Latest Report on OSCR

Insider Activity

In related news, CFO Richard Scott Blackley sold 68,978 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now owns 884,213 shares of the company's stock, valued at approximately $15,906,991.87. This trade represents a 7.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total value of $426,250.00. Following the completion of the sale, the director now owns 89,512 shares of the company's stock, valued at approximately $1,526,179.60. The trade was a 21.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 194,569 shares worth $3,433,319. Company insiders own 25.11% of the company's stock.

Oscar Health Price Performance

Shares of OSCR stock traded up $1.10 on Monday, reaching $18.43. 6,360,907 shares of the company were exchanged, compared to its average volume of 3,420,715. The company has a market cap of $4.56 billion, a price-to-earnings ratio of -311.67 and a beta of 1.67. Oscar Health, Inc. has a 1 year low of $7.50 and a 1 year high of $23.79. The business has a 50-day moving average price of $17.33 and a 200 day moving average price of $17.99. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion for the quarter, compared to analysts' expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health's quarterly revenue was up 68.3% on a year-over-year basis. During the same quarter last year, the firm posted ($0.29) earnings per share. Equities research analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Oscar Health Company Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Stories

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Should you invest $1,000 in Oscar Health right now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

AVGO is up 30% since earnings: could Broadcom be the next member of the Magnificent Seven? Can it sustain this momentum or is a pullback on the horizon?

Related Videos

Why Meta Is Still a Top Stock Pick for 2025
Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines